test

Marina Lalakin

@Sectoral Asset Management Inc

Latest period2024 - Q3ReportedManaged Assets$169.299MTotal holdings90
Assets growth rate-31.19%Assets growth rate (2-Q avg)-17.23%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Sectoral Asset Management Inc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 90 positions.

Assets under management

The assets under management (AUM) of Sectoral Asset Management Inc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 169.299M in assets, with a quarterly growth rate of -31.19% and a 2-quarter average growth rate of -17.23%. The portfolio is managed by Marina Lalakin, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BMYBristol Myers Squibb
Recent Activity
Increased 66.67%
1.53%
$2.587M
50,000 shares@ $51.74 avg price
ZLABZai Lab Ltd
Recent Activity
Increased 3543.5%
1.04%
$1.759M
72,870 shares@ $24.15 avg price
EWEdwards Lifescience
Recent Activity
Increased 65.18%
1.01%
$1.706M
25,850 shares@ $66.0 avg price
NBIXNeurocrine Bioscienc
Recent Activity
Increased 218.05%
0.86%
$1.442M
12,515 shares@ $115.22 avg price
BPMCBlueprint Medicines
Recent Activity
Increased 287.54%
0.82%
$1.38M
14,920 shares@ $92.5 avg price
MLTXMoonlake Immunothera
Recent Activity
Increased 27.21%
0.82%
$1.374M
27,258 shares@ $50.42 avg price
LEGNLegend Biotech Corp
Recent Activity
Increased 1260%
0.79%
$1.325M
27,200 shares@ $48.73 avg price
ARVNArvinas Inc
Recent Activity
Increased 31.59%
0.67%
$1.129M
45,830 shares@ $24.64 avg price
GPCRStructure Therapeu
Recent Activity
Increased 82.53%
0.64%
$1.071M
24,395 shares@ $43.9 avg price
RCKTRocket Pharmaceutica
Recent Activity
Increased 246.24%
0.48%
$801,284
43,383 shares@ $18.47 avg price